🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
We will study the effects of intensive rehabilitation in PD on plasticity w...
Status
Unknown
Location
IRCCS Centro Neurolesi "Bonino-Pulejo"
Start Date
2021-02-10
Trial ID
NCT05786261
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of the...
Status
Completed
Location
Las Piñas Doctors Hospital
Start Date
2022-06-13
Trial ID
NCT05188677
Treatments Being Tested
The goal of this clinical trial is to learn if a bimodal stimulation device...
Status
Unknown
Location
Multiple Locations
Start Date
2024-08
Trial ID
NCT06508060
Treatments Being Tested
The primary objective of this preschool intervention trial was to determine...
Status
Completed
Location
Hebrew University
Start Date
2000-09
Trial ID
NCT00610376
Treatments Being Tested
This study is a multicenter, double-blind, randomized, prospective phase 2 ...
Status
Unknown
Location
GAUZ Bryansk City Hospital No. 1
Start Date
2019-05-31
Trial ID
NCT05189002
Treatments Being Tested
The HIV Vaccine Trials Network (HVTN) is doing a study to test a new HIV va...
Status
Completed
Location
CAPRISA eThekwini CRS
Start Date
2015-02-02
Trial ID
NCT02404311
This study will evaluate the safety, tolerability, and descriptive efficacy...
Status
Active Not Recruiting
Location
UC San Diego Health
Start Date
2019-10-18
Trial ID
NCT03958877
Treatments Being Tested
This study in healthy human volunteers will investigate the effects of a si...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2022-05-11
Trial ID
NCT05195723
A double-blind study to characterize the effect of ampreloxetine on cardiac...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-01-18
Trial ID
NCT04688632